<DOC>
	<DOCNO>NCT02210702</DOCNO>
	<brief_summary>This prospective , randomize , control cohort study . This study look effect Ethinyl Estradiol 35mcg/Norethindrone 1mg Ethinyl Estradiol 20 mcg/Norethindrone 1mg postpartum depressive symptom sexual function score compare control group use hormonal contraception . Depressive symptom sexual function measure use Edinburgh Postnatal Depression Scale ( EPDS ) , Arizona Sexual Experiences Scale ( ASEX ) , Brief Index Sexual Functioning Women ( BISF-W ) . Participants begin take medication Week 3 postpartum , outcomes measure baseline ( 0-1 day postpartum ) , Week 3 , Week 6-7 . The investigator hypothesize ethinyl estradiol dose related response EPDS , ASEX , BISF-W score Week 6-7 , would indicate decrease depressive symptom increase sexual function oral contraceptive group .</brief_summary>
	<brief_title>Oral Contraceptive Ethinyl Estradiol Dose Effect Postpartum Depression Sexual Functioning Scales</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>1845 year old woman desire contraception postpartum least 6 week . 1845 year old woman choose use oral contraceptive medication postpartum least 6 week control group . Exclusion Criteria ( Medication group ) : Breastfeeding ( although may limit participant enrollment , combine oral contraceptive contraindicate population ) . Delivery cesarean section . Previous history depression , mood disorder , psychiatric disorder . Any condition ( history presence ) contraindicate use combination OCs , include : Thrombophlebitis thromboembolic disorder , know suspect clot disorder , deep vein thrombosis , thrombogenic valvulopathies rhythm disorder . Pulmonary Embolism . Cerebrovascular coronary artery disease myocardial infarction . Diabetes mellitus . Migraine headaches focal , neurological symptom . Chronic renal disease . Uncontrolled untreated hypertension . Cholestatic jaundice . Known suspected carcinoma breast , endometrial carcinoma , know suspected estrogendependent neoplasia . Impaired liver function disease , hepatic adenoma carcinoma . Known hypersensitivity estrogens and/or progestin . History thyroid disorder . Recent alcohol drug use . Smoking age â‰¥35 smoker become 35 year age study . Known history noncompliance take medication . Exclusion Criteria ( Control group ) : Previous history depression , mood disorder , psychiatric disorder . Recent alcohol drug use .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>